Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletions

No abstract is available for this paper.

• Publication year

  2000

• Venue

  European Journal of Human Genetics

• Publication date

  2000-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.ejhg.5200571PMID 11175283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic locus heterogeneity in Lafora's progressive myoclonus epilepsy

  1999cited by this paper
• Isolation and characterization of mouse homologue for the human epilepsy gene, EPM2A.

  1999cited by this paper
• A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2).

  1999cited by this paper
• Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy

  1998cited by this paper
• A comprehensive genetic map of the human genome based on 5,264 microsatellites

  1996cited by this paper
• The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q.

  1995cited by this paper
• Lafora disease: A progressive myoclonus epilepsy

  1992cited by this paper
• The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions

  1990cited by this paper
• Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

  1989cited by this paper
• Progressive myoclonus epilepsies: specific causes and diagnosis.

  1986cited by this paper
• La Maladie De Lafora

  1978cited by this paper
• [Lafora disease (author's transl)].

  1978cited by this paper
• Studies in myoclonus epilepsy (Lafora body form)

  1970cited by this paper
• Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases.

  1968cited by this paper
• [Myoclonus epilepsy].

  1955cited by this paper
• Beitrag zur Histopathologie der myoklonischen Epilepsie

  1911cited by this paper

• Ethnic and Epidemiological Peculiarities of Movement Disorders across the World.

  2025cites this paper
• Axonal polyneuropathy in Lafora disease with a newly identified EPM2A mutation: a case report and review of literature

  2025cites this paper
• Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a-/- mice.

  2023cites this paper
• An empirical pipeline for personalized diagnosis of Lafora disease mutations

  2021cites this paper
• Genotypes and phenotypes of patients with Lafora disease living in Germany

  2019cites this paper
• Disorders of Carbohydrate Metabolism

  2018cites this paper
• Lafora Disease: Molecular Etiology

  2018cites this paper
• Lafora disease: from genotype to phenotype

  2018cites this paper
• Identification of a Novel Homozygous Splice-Site Mutation in SCARB2 that Causes Progressive Myoclonus Epilepsy with or without Renal Failure

  2018cites this paper
• Análisis del perfil de interacción de diferentes mutantes patológicos en laforina mediante ensayos de doble híbrido en levadura.

  2017cites this paper
• Clinical and genetic data on Lafora disease patients of Serbian/Montenegrin origin

  2016cites this paper
• Lafora disease.

  2016cites this paper
• Three Patients With Lafora Disease

  2015cites this paper
• Genetic Counselling in Epilepsy

  2015cites this paper
• Late onset Lafora disease and novel EPM2A mutations: breaking paradigms.

  2014cites this paper
• Molecular Dynamics Simulations and Principal Component Analysis on Human Laforin Mutation W32G and W32G/K87A

  2014cites this paper
• Lafora disease: Mechanisms involved in pathogenesis

  2014cites this paper
• Epilepsia mioclónica progresiva tipo Lafora y los casos diagnosticados en Costa Rica

  2014cites this paper
• Lafora disease: severe phenotype associated with homozygous deletion of the NHLRC1 gene.

  2013cites this paper
• Exploring the Structural Insights on Human Laforin Mutation K87A in Lafora Disease—A Molecular Dynamics Study

  2013cites this paper
• Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities.

  2013cites this paper
• Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice.

  2012cites this paper
• Four novel and two recurrent NHLRC1 (EPM2B) and EPM2A gene mutations leading to Lafora disease in six Turkish families.

  2012cites this paper
• A PTG Variant Contributes to a Milder Phenotype in Lafora Disease

  2011cites this paper
• Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora disease

  2010influential citation
• Lafora disease

  2010cites this paper
• Lafora progressive myoclonus epilepsy: A meta‐analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes

  2009cites this paper
• Genetic diagnosis in Lafora disease

  2007cites this paper
• [Lafora's disease (EPM2)].

  2007cites this paper
• La maladie de Lafora (EPM2)

  2007cites this paper
• A 12‐YEAR‐OLD GIRL WITH SEIZURES AND DEMENTIA

  2007cites this paper
• Glycogen metabolism in tissues from a mouse model of Lafora disease.

  2007cites this paper
• Founder Effect with Variable Age at Onset in Arab Families with Lafora Disease and EPM2A Mutation

  2007cites this paper
• Hepatic disease as the first manifestation of progressive myoclonus epilepsy of Lafora

  2007cites this paper
• Relationship between glycogen accumulation and the laforin dual specificity phosphatase.

  2006cites this paper
• Novel NHLRC1 mutations and genotype–phenotype correlations in patients with Lafora’s progressive myoclonic epilepsy

  2006cites this paper
• Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy

  2006cites this paper
• Clinical and Genetic Findings in 26 Italian Patients with Lafora Disease

  2006cites this paper
• Lafora progressive myoclonus epilepsy mutation database‐EPM2A and NHLRC1 (EMP2B) genes

  2005cites this paper
• A founder mutation in the CLCNKB gene causes Bartter syndrome type III in Spain

  2005cites this paper
• Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population

  2005influential citation
• Loss of function of the cytoplasmic isoform of the protein laforin (EPM2A) causes Lafora progressive myoclonus epilepsy

  2004cites this paper
• [Lafora's progressive myoclonus epilepsy and diagnosed cases in Costa Rica].

  2004cites this paper
• The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.

  2004cites this paper
• [Non-convulsive epileptic status associated with Lafora disease: two case reports].

  2003cites this paper
• Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.

  2003cites this paper
• Bioptically demonstrated Lafora disease without EPM2A mutation: a clinical and neurophysiological study of two sisters.

  2003cites this paper
• Two novel mutations in the EPM2A gene in a Korean patient with Lafora's progressive myoclonus epilepsy

  2003cites this paper
• Progressive myoclonus epilepsy in a beagle.

  2003cites this paper
• The Lafora disease gene product laforin interacts with HIRIP5, a phylogenetically conserved protein containing a NifU-like domain.

  2003cites this paper
• [Lafora disease. A new case of confirmation of diagnosis on molecular genetic studies].

  2002cites this paper
• Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.

  2002cites this paper
• Genetics of epilepsy: current status and perspectives.

  2002cites this paper
• A Unique Carbohydrate Binding Domain Targets the Lafora Disease Phosphatase to Glycogen*

  2002cites this paper
• Regional and developmental expression of Epm2a gene and its evolutionary conservation.

  2001cites this paper
• Advances in the genetics of progressive myoclonus epilepsy.

  2001cites this paper